This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Article Abstract
During the reproductive years, depression is common in women, and many face treatment decisions during pregnancy. Possible risks of untreated maternal depression include increased risk of relapse and postpartum depression, all the serious risks associated with the untreated disorder in nonpregnant women, and obstetrical complications. Data on teratogenic risks of antidepressant use are inconsistent, but these risks should be taken into consideration. Overall, treatment should be individually tailored, and nonpharmacologic options may be appropriate.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Vol 87 • 2026 • Number 3
Read the Current Issue
Original Research
Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression
Original Research
US Mortality Involving Obesity and Psychiatric Disorders
Academic Highlights
Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report
Original Research
Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms
Original Research
Exposure-Based Video Therapy for OCD and PTSD
Original Research
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
Insightful. Evidence-based. Human-centered.
Listen Now